Stock events for Synergy CHC Corp. (SNYR)
Synergy CHC Corp.'s stock experienced fluctuations, declining by 57.24% between December 30, 2024, and December 26, 2025, and 55.56% over the last 12 months. However, it increased by 1.90% in the past month as of January 12, 2026. In September 2025, the company completed a $4.3 million stock offering. The third-quarter 2025 financial results were reported on November 13, 2025, marking the eleventh consecutive profitable quarter, with revenue increasing by 12.4% year-over-year, but net income declined. Roth Capital Partners reaffirmed a "Buy" rating in November and December 2025. The CEO, Jack Ross, made an insider purchase of shares in July 2025.
Demand Seasonality affecting Synergy CHC Corp.’s stock price
Information regarding specific demand seasonality for Synergy CHC Corp.'s products and services was not found in the provided search results.
Overview of Synergy CHC Corp.’s business
Synergy CHC Corp. is a consumer healthcare, beauty, and lifestyle products company operating within the Healthcare sector. It offers a diverse portfolio of products, including brain health supplements under the FOCUSfactor brand, lifestyle and wellness products under the Flat Tummy brand, and other brands like Hand MD, Perfekt Beauty, Sneaky Vaunt, The Queen Pegasus, Neuragen, and UrgentRx.
SNYR’s Geographic footprint
Synergy CHC Corp. distributes its products in the United States, Canada, and the United Kingdom. The company is expanding internationally, including shipments to Costco Mexico and licensing partnerships in the UAE and Turkey.
SNYR Corporate Image Assessment
Synergy CHC Corp. has seen positive developments in its brand reputation, particularly for FOCUSfactor, which was named the #1 Pharmacist Recommended OTC Memory Supplement for 2025-2026. The company has been expanding the distribution of FOCUSfactor functional beverages through new partnerships and into over 1,600 EG America convenience stores.
Ownership
Synergy CHC Corp. has a mix of institutional and individual owners, with 15 institutional owners holding 1,649,934 shares. Major institutional shareholders include Gratia Capital, LLC, Heartland Advisors Inc., Sanders Morris Harris LLC, Vanguard Group Inc., Warberg Asset Management LLC, Geode Capital Management, LLC, Virtu Financial LLC, Knight Therapeutics Inc., Gowan Capital, Inc., Dunhill Distribution Group, Inc., Paloma Partners Management Co, XTX Topco Ltd, Citigroup Inc, UBS Group AG, and Bank Of America Corp /De/. Jack Ross is the largest individual shareholder, owning 4.80 million shares, representing 42.62% of the company.
Ask Our Expert AI Analyst
Price Chart
$1.82
